COORDINATED CARE IN CUSHING DISEASE

Slides:



Advertisements
Similar presentations
Characteristics and Treatment of Common Endocrine Disorders
Advertisements

Cushing’s Syndrome Britni Hebert PGY 2 4/9/10 Notes located in presenter note section below each slide.
ADRENAL CORTEX CUSHING, CONN AND ADDISON DISEASE CUSHING, CONN AND ADDISON DISEASE Snježana Vukelić Mentor: A. Žmegač Horvat.
 Located above the kidneys like a hat for them.
Endocrine Disorders.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 60 Drugs for Disorders of the Adrenal Cortex.
description  Cushing’s disease is a condition in which the pituitary gland releases too much adrenocorticotropic hormone (ACTH).
13 Lecture Notes Endocrine System
Beyond pituitary surgery: Radiosurgery vs. Adrenalectomy vs Medical Treatment when Cushing’s disease persists or recurs Theodore C. Friedman, M.D., Ph.D.
Cushing’s Syndrome.
Check your knowledge in… Adrenal diseases. Which treatment is indicated in case of hyperaldosteronism due to adrenal hyperplasia? 1.Medical treatment.
This lecture was conducted during the Nephrology Unit Grand Ground by Registrar under Nephrology Division under the supervision and administration of Prof.
Gigantism By: Colby Dahlke.
Cushing’s Syndrome Stephen Ou R2 May 17, Learning Objectives Discuss the different etiologies of hypercortisolism. Recognize the clinical manifestations.
Armed Forces Academy of Medical Sciences
1QQ # 4: Answer one. 1.Starting with a drop in blood pressure, diagram the sequence of events that begins with the secretion of renin and ends with responses.
Thyroid and Adrenal glands The endocrine system problems.
Cushing’s syndrome Zhaoxiaojuan. Effects of glucocorticoid Effects on metabolism Effects on immunologic function and inflammatory Effects on musculoskeletal.
Cushing's syndrome Abdullah Alhowidi Definition Cushing's syndrome is a characteristic group of manifestations caused by excessive circulating.
A.C.T.H. Adrenocorticotropic Hormone Brittany Rupp.
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 60 Drugs for Disorders of the Adrenal Cortex.
Addison’s Disease MS II. Endocrine2 Adrenal Glands Adrenal Medulla – Responds to SNS stimulation – Secretes catecholamines – epinephrine is the main player.
Where Are We on the Path to Elimination of Chronic Hepatitis C?
Assistant lecturer of Pediatrics
Dry Eye Disease: Pathophysiology, Symptoms, Intervention
Multimodal Management of Opioid-Induced Constipation
This PowerPoint document contains the images that you requested.
Biochemical Predictors of Outcome of Pituitary Surgery for Cushing’s Disease Neuroendocrinology 2010;91:169–178 - DOI: / © 2009 S. Karger.
The Patient Experience With Systemic Lupus Erythematosus
The Nurse View: Management of Pancreatic Cancer
MLAB 2401: Clinical Chemistry Keri Brophy-Martinez
Assessing COPD in Primary Care
Deciphering Obesity Management Guidelines
Program Goals. Out of the Periphery and Into Comprehensive Care: Managing Diabetic Peripheral Neuropathy.
A Multidisciplinary Team Approach Challenges and Best Practices in Cushing Disease.
Primary Care Challenges in Depression - To Treat or Refer?
ICD-10 and Clinical Documentation
Bipolar I Depression Today: The Evolving Understanding of Bipolar Depression Neurobiology and the Relation to Diagnosis.
Adrenal Disorders (PED474)
Adrenal Glucocorticoid Hyperfunction (Cushing’s Syndrome)
The Patient Journey to Remission in MDD: A Collaborative Approach
Renal and Extrarenal Complications of ADPKD: Facilitating Better Patient Care.
Standards of Care in Duchenne Muscular Dystrophy: A 2018 Update
Reassessing the Role of Somatostatin Analogs in the Treatment of NETs
Tailoring Hemophilia Prophylaxis Therapy
The Nurse View: Best Practices in Multiple Myeloma
Follow-Up of the Patient After PE
Updates in Neuronal Ceroid Lipofuscinosis
Talking to Patients About Diabetes Management
Tuberous Sclerosis Complex Fundamental Concepts in Diagnosis and Management.
Overview. Maximizing the Safety of CAR T-Cell Therapy: Prevention, Early Recognition, and Management.
Nat. Rev. Endocrinol. doi: /nrendo
Use of Mifepristone for Prevention of Adrenal Insufficiency Following
ADVANCED PARKINSON'S DISEASE:
When Is Biologic Therapy Appropriate for HS?
Nurse View: Practice Pearls in Advanced Pancreatic Adenocarcinoma
Physician Diagnosis and Prescription
Case 1 Presentation Case 1 (cont) Assessment and Recommendations.
Theodore C. Friedman, M.D., Ph.D. Symposium on Cushing’s Syndrome
Managing HF in Primary Care
Updates in Neuronal Ceroid Lipofuscinosis
Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC
Management of Advanced Pancreatic Adenocarcinoma
Are We Making Progress in the Management of Huntington Disease?
Perspective on the Multidisciplinary Management of PAH
A Multidisciplinary Perspective on the Management of Hypoparathyroidism.
What Does BRCA Have to Do With It? PARP Inhibitors in Ovarian Cancer
Importance of Early Diagnosis and Management in SMA
Interprofessional Approach to Managing Adverse Events of PI3K Inhibitors.
Women With Psoriasis Are Struggling More Than Men
Presentation transcript:

COORDINATED CARE IN CUSHING DISEASE

Program Goals

Cushing Disease: Importance of Diagnosis

Patient Case

Symptoms of Cushing Disease

Physical Findings for Cushing Disease

Diagnostic Tests

Determining Cause of Cortisol Excess

Determining Source of Excess ACTH

Patient Case: Results of Testing

If Tumor Is Successfully Removed

Patient Case Follow-Up

Radiation to the Pituitary

Bilateral Adrenalectomy

Pharmacotherapy for Cushing Disease

Pharmacotherapy for Cushing Disease

Steroidogenesis Inhibitors*

Pasireotide

Mifepristone

Closing Comments

Abbreviations

References

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)